TrialThe Journal of antimicrobial chemotherapy2022

Population pharmacokinetics of intravenous cefotaxime indicates that higher doses are required for critically ill children.

Stan J F Hartman et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.